Search - tctmd.com

Displaying 81 - 100 of 204

Sort: Relevancy | Date

News Conference News TCT 2014

Thoughtful Insights at TCT: Dealing With Complex CAD Cases

Todd Neale

October 17, 2014

Presentation TCT 2014

Chronic Renal Failure: An Emerging Important Risk Modifier in Patients with Multivessel CAD with and without Diabetes?

Presenter: George D. Dangas, Michael E. Farkouh, Usman Baber

September 16, 2014

News Conference News TCT 2014

Keynote Address Focuses on Newer DES, Problematic Subgroups

September 15, 2014

News Industry News

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

September 15, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Eric A. Cohen, Dean J. Kereiakes, Samer Mansour

September 14, 2014

Presentation TCT 2014

How Would I Treat This Patient?

Presenter: Eric A. Cohen, Dean J. Kereiakes, Stuart Watkins

September 14, 2014

Presentation TCT 2014

Case #3. Multivessel Disease in a Stable CAD Patient

Presenter: Eric A. Cohen, Dean J. Kereiakes, Samer Mansour

September 14, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Dean J. Kereiakes, Margaret B. McEntegart, Stuart Watkins, Colin Berry

September 14, 2014

Presentation TCT 2014

Case #2: Multivessel Disease in an NSTEMI Patient

Presenter: Dean J. Kereiakes, Margaret B. McEntegart, Stuart Watkins, Colin Berry

September 14, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Dean J. Kereiakes, Margaret B. McEntegart, Stuart Watkins, Keith G. Oldroyd

September 14, 2014

News Conference News TCT 2014

SMILE: One-Stage PCI Superior for Non-STEMI and Multivessel CAD

September 14, 2014

News Industry News

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

September 14, 2014

Presentation TCT 2014

Case Reviews: iFR to Guide PCI in Diffuse and Multivessel CAD

Presenter: Javier Escaned, Habib Samady, Justin E. Davies

September 13, 2014

News Daily News

欧洲学会发布更新后的CAD血运重建指南

L.A. McKeown

September 11, 2014

News Daily News

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

September 11, 2014

News Daily News

European Societies Release Updated Revascularization Guidelines for CAD

L.A. McKeown

September 11, 2014

News Daily News

Las PCI Solo del Vaso Causante Podrían ser Mejores en Pacientes IM con Enfermedad Multivaso y Shock Cardiogénico

September 11, 2014

News Conference News ESC 2014

FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years

Caitlin E. Cox

September 02, 2014

News Conference News ESC 2014

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Yael L. Maxwell

September 01, 2014

News Conference News ESC 2014

Observational Studies Ask How Much Medication Adherence Matters After MI

Caitlin E. Cox

August 31, 2014

Advertisement

Thoughtful Insights at TCT: Dealing With Complex CAD Cases

Chronic Renal Failure: An Emerging Important Risk Modifier in Patients with Multivessel CAD with and without Diabetes?

Keynote Address Focuses on Newer DES, Problematic Subgroups

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

How Did I Treat This Patient?

How Would I Treat This Patient?

Case #3. Multivessel Disease in a Stable CAD Patient

How Did I Treat This Patient?

Case #2: Multivessel Disease in an NSTEMI Patient

How Did I Treat This Patient?

SMILE: One-Stage PCI Superior for Non-STEMI and Multivessel CAD

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

Case Reviews: iFR to Guide PCI in Diffuse and Multivessel CAD

欧洲学会发布更新后的CAD血运重建指南

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

European Societies Release Updated Revascularization Guidelines for CAD

Las PCI Solo del Vaso Causante Podrían ser Mejores en Pacientes IM con Enfermedad Multivaso y Shock Cardiogénico

FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Observational Studies Ask How Much Medication Adherence Matters After MI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content